Nalaganje...
OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-κB pathway
AIMS: Oxidatively modified lipoproteins may promote the development/progression of calcific aortic valve stenosis (CAVS). Oxidative transformation of low-density lipoprotein (OxLDL) generates lysophosphatidic acid (LPA), a lipid mediator that accumulates in mineralized aortic valves. LPA activates a...
Shranjeno v:
| izdano v: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5852522/ https://ncbi.nlm.nih.gov/pubmed/28472283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvx089 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|